Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis

Cancer

Volumn 95, Issue 8, 2002, Pages 1802-1815

  Capo Chichi, Callinice D ^a   Smith, Elizabeth R ^a   Yang, Dong Hua ^a   Roland, Isabelle H ^a   Vanderveer, Lisa ^a   Cohen, Cynthia ^b   Hamilton, Thomas C ^a   Godwin, Andrew K ^a   Xu, Xiang Xi ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basement membrane; Cell positioning and organization; Collagen IV; Disabled 2 (Dab2); Epithelium; Extracellular matrix; Laminin; Metastasis; Ovarian carcinoma; Premalignant lesion

Indexed keywords

CELL PROTEIN; COLLAGEN TYPE 4; LAMININ; MEMBRANE PROTEIN; PROTEIN DISABLED 2; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER GRADING; CARCINOGENESIS; CELL TRANSPLANTATION; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURFACE PROPERTY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; BASEMENT MEMBRANE; BLOTTING, NORTHERN; COLLAGEN TYPE IV; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0037108285     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10870     Document Type: Article

References (72)

1. Martin GR, Rohrbach DH, Terranova VP, Liotta LA. Structure, function, and pathology of basement membranes. Monogr Pathol. 1983;24:16-30.
2. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development. 1993; 117:1183-1198.
3. Timpl R, Dziadek M. Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol. 1986;29:1-112.
4. Stenbeck F, Wasenius V-M. Basement membrane structures in tumors of the ovary. Eur J Obstet Gynecol Reprod Biol. 1985;20:357-371.
5. Auersperg N, Maclaren IA, Kruk PA. Ovarian surface epithelium: autonomous production of connective tissue-type extracellular matrix. Biol Reprod. 1991;44:717-724.
6. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001;22:255-288.
7. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996;12:1895-1901.
8. Bast RC Jr., Boyer CM, Jacobs I, et al. Cell growth regulation in epithelial ovarian cancer. Cancer. 1993;15:1597-1601.
9. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol. 1998;25: 281-304.
10. Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res. 1994; 215:97-108.
11. LeMaire WJ. Mechanism of mammalian ovulation. Steroids. 1989;54:455-469.
12. Beers WH, Strickland S, Reich E. Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell. 1975;6:387-394.
13. Canipari R, Strickland S. Studies on the hormonal regulation of plasminogen activator production in the rat ovary. Endocrinology. 1986;118:1652-1659.
14. Canipari R, O'Connell ML, Meyer G, Strickland S. Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J Cell Biol. 1987;105:977-181.
15. Mukaida T, Morioka N, Zhu C, Butler TA, Lemaire WJ, Woessner JF Jr. Plasmin activation of collagenase during ovulation in the perfused rat ovary. Matrix Suppl. 1992;1: 402-403.
16. Butler TA, Zhu C, Mueller RA, Fuller GC, Lemaire WJ, Woessner JF Jr. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol Reprod. 1991;44:1183-1188.
17. Morales TI, Woessner JF Jr., Marsh JM, LeMaire WJ. Collagen, collagenase and collagenolytic activity in rat Graafian follicles during follicular growth and ovulation. Biochim Biophys Acta. 1983;756:119-122.
18. Downs SM, Longo FJ. Prostaglandins and preovulatory follicular maturation in mice. J Exp Zool. 1983;228:99-108.
19. Downs SM, Longo FJ. An ultrastructural study of preovulatory apical development in mouse ovarian follicles: effects of indomethacin. Anat Rec. 1983;205:159-168.
20. Downs SM, Longo FJ. Effects of indomethacin on preovulatory follicles in immature, superovulated mice. Am J Anat. 1982;164:265-274.
21. Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia? Lancet. 1971;2:163.
22. Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf). 1998;49:695-707.
23. Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development. Cancer. 1993;71:530-536.
24. Godwin AK, Testa JR, Handel LM, et al. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst. 1992;84:592-601.
25. Stadel BV. Letter: the etiology and prevention of ovarian cancer. Am J Obstet Gynecol. 1975;123:772-774.
26. Zheng W, Lu JJ, Luo F, et al. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol. 2000; 76:80-88.
27. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-626.
28. Hagios C, Lochter A, Bissell MJ. Tissue architecture: the ultimate regulator of epithelial function? Phil Trans R Soc Lond [B]. 1998;353:857-870.
29. Bissell MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci. 1987;8:327-343.
30. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267:891-893.
31. Richardson GS, Scully RE, Nikrui N, Nelson JH Jr. Common epithelial cancer of the ovary (2). N Engl J Med. 1985;312: 474-483.
32. Bell DA, Scully RE. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 1994;73:1859-1864.
33. Aoki Y, Kawada N, Tanaka K. Early form of ovarian cancer originating in inclusion cysts. A case report. J Reprod Med. 2000;45:159-161.
34. Scully RE. Pathology of ovarian cancer precursors. J Cell Biochem Suppl. 1995;23:208-218.
35. Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001;38:87-95.
36. De Palo G. Staging and treatment of ovarian carcinoma. Acta Oncol. 1989;28:163-176.
37. Lauchlan SC. Non-invasive ovarian carcinoma. Int J Gynecol Pathol. 1990;9:158-169.
38. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer. 1990; 65:578-585.
39. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998;82:1096-1103.
40. Dauplat J, Hacker NF, Nieberg RK, Berek JS, Rose TP, Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60:1561-1566.
41. Clark WH Jr. The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. Acta Oncol. 1995;34:3-21.
42. Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene. 2000;19: 4847-4854.
43. Skubitz APN, Bast RC, Wayner EA, Letourneau PC, Wilke MS. Expression of β6 and α4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am J Pathol. 1996;148:1445-1461.
44. Byers LJ, Osborne JL, Carson LF, et al. Increased levels of laminin in ascitic fluid of patients with ovarian cancer. Cancer Lett. 1995;88:67-72.
45. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest. 1983;49:140-147.
46. Campo E, Merino MJ, Tavassoli FA, et al. Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol. 1992;16:500-507.
47. Visser R, Arends JW, Bosman FT. Basement membrane patterns in borderline tumors of the ovary. An immunohistochemical study with antibodies to laminin and type IV collagen. Int J Gynecol Cancer. 1995;5:286-290.
48. De Nictolis M, Garbisa S, Lucarini G, et al. 72-Kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and serological study. Int J Gynecol Pathol. 1996;15:102-109.
49. Kuwashima Y, Uehara T, Kurosumi M, et al. Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin. Eur J Gynaecol Oncol. 1995;16:181-186.
50. Mikami Y, Hata S, Melamed J, Moriya T, Manabe T. Basement membrane material in ovarian clear cell carcinoma: correlation with growth pattern and nuclear grade. Int J Gynecol Pathol. 1999;18:52-57.
51. Orre M, Rogers PA. Reduced vascular basement-membrane immunostaining in mucinous tumours of the ovary. Int J Cancer. 1998;79:139-143.
52. Iwahashi M, Ikoma M, Otani T, Ooshima A, Nakano R. Increased serum concentrations of type IV collagen and laminin associated with granulosa cell tumour of the ovary. J Clin Pathol. 1997;50:77-79.
53. Yang DH, Smith ER, Cohen C, et al. Molecular events associated with dysplastic morphological transformation and initiation of ovarian tumorigenicity. Cancer. 2002;94:2380-2392.
54. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer. 1994;58:50-56.
55. Liotta LA, Abe S, Robey PM, Martin GR. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci USA. 1979;76:2268-2272.
56. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67-68.
57. Crawford HC, Matrisian LM. Tumor and stromal expression of matrix metalloproteinase and their role in tumor progression. Invasion Metastasis. 1994;14:234-245.
58. Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC Jr., Stack MS. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer. 1994;56:552-559.
59. Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000;77:369-376.
60. Moore DH, Allison B, Look KY, Sutton GP, Bigsby RM. Collagenase expression in ovarian cancer cell lines. Gynecol Oncol. 1997;65:78-82.
61. Liebman JM, Burbelo PD, Yamada Y, Fridman R, Kleinman HK. Altered expression of basement-membrane components and collagenases in ascitic xenografts of OVCAR-3 ovarian cancer cells. Int J Cancer. 1993;55:102-109.
62. Cohen C. Image cytometric analysis in pathology. Hum Pathol. 1996;27:482-493.
63. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu X. Loss of Disabled-2 is an early step in ovarian tumorigenicity. Oncogene. 1999;18:3104-3113.
64. Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera S, Auersperg N. Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer. 1996;69:429-436.
65. Grobelny JV, Godwin AK, Broccoli D. ALT-associated PML bodies (AA-PBs) are dynamic structures that accumulate in G2/M phase of the cell cycle. J Cell Sci. 2000;113:4577-4585.
66. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA. 1992;89:3070-3074.
67. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
68. Sheng Z, He J, Sun W, et al. Structure and sequence of human Disabled-2 gene. Genomics. 2000;70:381-386.
69. Mok SC, Wong KK, Chan RWK, et al. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol. 1994;52:247-252.
70. Mok SC, Chan WY, Wong KK, et al. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 1998;16:2381-2387.
71. Li X, Talts U, Talts JF, Arman E, Ekblom P, Lonai P. Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane. Proc Natl Acad Sci USA. 2001;98:14416-14421.
72. Hagedorn HG, Bachmeier BE, Nerlich AG. Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas [Review]. Int J Oncol. 2001;18:669-681.